Author

Mithun V. Shah

Observed name: Shah, Mithun V.

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5124905095

Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents

2026 · Saubia Fathima, Margaret Mei‐Kay Wong, et al. · American Journal of Hematology · 2

TP53 Mutations and Circulating Blasts ≥ 20% Are the Primary Determinants of Survival in Accelerated/Blast‐Phase Myeloproliferative Neoplasms Treated With Frontline Venetoclax Plus Hypomethylating Agent

2026 · Naseema Gangat, Momna Warraich, et al. · American Journal of Hematology · 1

Clinical outcomes of venetoclax combined with hypomethylating agents versus hypomethylating agents alone in TP53-mutated myelodysplastic syndromes

2026 · Mahmood Aldapt, Yu-Hung Wang, et al. · Haematologica · 1

Local disease control in patients with Erdheim–Chester disease treated with external beam radiation therapy

2026 · Kessel, Adam C., Burlile, Jessica F., et al. · PubMed Central

Comparative Efficacy of Donor Lymphocyte Infusions in Augmenting Graft-versus-Leukemia Effect after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Myeloid Malignancies

2026 · Maymona Abdelmagid, Naima J. Hashi, et al. · Acta Haematologica

Dynamic-EASIX DRI Model: A Novel Tool for Predicting Outcomes After Allogeneic Hematopoietic Cell Transplantation

2026 · Anmol Baranwal, Rabee Kassis, et al. · Transplantation and Cellular Therapy

AI Multimodal Large Language Model on CAR-T Pre-Leukapheresis Evaluation to Predict Monitoring Needs Post Infusion for Early Dismissal Planning

2026 · Andre de Menezes Silva Corraes, Emmanuel Contreras Guzman, et al. · Transplantation and Cellular Therapy

Post-Transplant Cyclophosphamide, Abatacept, and Short Course of Tacrolimus As Gvhd Prophylaxis - a Mayo Clinic Experience

2026 · Hassan B. Alkhateeb, Anmol Baranwal, et al. · Transplantation and Cellular Therapy

Impact of Reduced-Dose Post-Transplant Cyclophosphamide in Early Cardiac Events and Allogeneic Stem Cell Transplant Outcomes

2026 · Aldo A Acosta Medina, Ishaan Garg, et al. · Transplantation and Cellular Therapy

Molecular profiling is critical to guide MEK inhibitor use in Erdheim-Chester disease

2025 · Gaurav Goyal, Aldo A. Acosta-Medina, et al. · Leukemia

Works count: 10

Citation count: 4

H-index: 1

I10-index: